Cystic fibrosis transmembrane conductance regulator activation by roflumilast contributes to therapeutic benefit in chronic bronchitis.
about
Mucociliary dysfunction in HIV and smoked substance abuseOral Apremilast for the Treatment of Plaque PsoriasisThe chronic bronchitis phenotype in chronic obstructive pulmonary disease: features and implicationsAirway hydration and COPDRACK1 and β-arrestin2 attenuate dimerization of PDE4 cAMP phosphodiesterase PDE4D5Drug safety evaluation of roflumilast for the treatment of COPD: a meta-analysis.Genetic susceptibility for chronic bronchitis in chronic obstructive pulmonary disease.Airway Surface Dehydration Aggravates Cigarette Smoke-Induced Hallmarks of COPD in Mice.Acquired Cystic Fibrosis Transmembrane Conductance Regulator Dysfunction in Chronic Bronchitis and Other Diseases of Mucus ClearanceTherapeutic Approaches to Acquired Cystic Fibrosis Transmembrane Conductance Regulator Dysfunction in Chronic Bronchitis.CFTR: A New Horizon in the Pathomechanism and Treatment of Pancreatitis.Impact of heterozygote CFTR mutations in COPD patients with chronic bronchitis.Roflumilast and aquaporin-2 regulation in rat renal inner medullary collecting duct.Roflumilast combined with adenosine increases mucosal hydration in human airway epithelial cultures after cigarette smoke exposure.Roflumilast reverses CFTR-mediated ion transport dysfunction in cigarette smoke-exposed mice.Co-inhalation of roflumilast, rather than formoterol, with fluticasone more effectively improves asthma in asthmatic mice.Recovery of Acquired Cystic Fibrosis Transmembrane Conductance Regulator Dysfunction after Smoking Cessation.Roflumilast partially reverses smoke-induced mucociliary dysfunction.The PDE4 cAMP-Specific Phosphodiesterases: Targets for Drugs with Antidepressant and Memory-Enhancing Action.Toward inclusive therapy with CFTR modulators: Progress and challenges.The Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Ivacaftor Augments Mucociliary Clearance Abrogating Cystic Fibrosis Transmembrane Conductance Regulator Inhibition by Cigarette Smoke.Management of Common Side Effects of Apremilast.The therapeutic potential of CFTR modulators for COPD and other airway diseases.Cigarette Smoke-Induced Acquired Dysfunction of Cystic Fibrosis Transmembrane Conductance Regulator in the Pathogenesis of Chronic Obstructive Pulmonary Disease.The EGFR-ADAM17 Axis in Chronic Obstructive Pulmonary Disease and Cystic Fibrosis Lung Pathology.
P2860
Q26777222-5FBE2CDC-9CDB-436B-898C-8BDAA8986C15Q28075724-0735FB44-A446-43E8-A5F9-029C4FC5E745Q28081970-9F62F8A5-215B-4CEB-9A0C-EA05C16FA079Q28082617-9163B3E6-A8FD-498A-ABFB-65D37B430124Q28386161-35C6C351-B2E0-4FEA-8E9E-1FB1E683520BQ30249747-93E72F4F-F576-4CCD-85C4-37DE02B7CAC4Q34309196-A98A000C-7EA9-4217-9141-F312F75A1FD5Q35661242-5EAB9C38-7DD0-411E-9AE7-4827881653DBQ36567237-EFA9FBF9-ED90-4AED-8BE1-0658CE6574ECQ37241561-E4B19352-9160-48FF-A2A7-77A225D240BDQ37583400-EF6AA442-B185-48B0-9676-81A4122D33A2Q37586134-83B162AB-C045-48DA-AB0D-3664574AB582Q37609062-C2B937A5-D155-4305-B153-059CE5987753Q40829135-AFB6841B-90D9-4403-9D81-B1CD89E1B3AAQ41710343-F7BA6897-80CE-4F7F-9360-107AF8245085Q42287278-D7EDEB9A-7A21-4B02-AA94-BD7927DB553CQ43062795-E5990C5B-E1A8-446E-909E-4D0BAC760746Q43194351-2F01E76A-9A2C-4F45-A181-B1BCA8E2B3A7Q47732733-419C5AA7-DA25-4C37-8C37-4CA499AF63C9Q47842086-04DC508D-6356-4A26-BB29-1312263141EEQ49073386-BDC277D8-5E00-4798-BAC0-DBD634F84DC1Q49382144-FE756E35-0053-4B35-A654-B664F3EA60C5Q50046887-A9E20407-7B18-442D-B435-1304C007F04AQ54962564-78C8F1CC-0F62-4535-A349-4CC9F8066BB6Q55177212-889F7F66-DFA8-4742-9DE4-C418838FBD3A
P2860
Cystic fibrosis transmembrane conductance regulator activation by roflumilast contributes to therapeutic benefit in chronic bronchitis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Cystic fibrosis transmembrane ...... benefit in chronic bronchitis.
@ast
Cystic fibrosis transmembrane ...... benefit in chronic bronchitis.
@en
type
label
Cystic fibrosis transmembrane ...... benefit in chronic bronchitis.
@ast
Cystic fibrosis transmembrane ...... benefit in chronic bronchitis.
@en
prefLabel
Cystic fibrosis transmembrane ...... benefit in chronic bronchitis.
@ast
Cystic fibrosis transmembrane ...... benefit in chronic bronchitis.
@en
P2093
P2860
P356
P1476
Cystic fibrosis transmembrane ...... benefit in chronic bronchitis.
@en
P2093
Clifford A Courville
George E Coricor
Graeme B Bolger
James A Lambert
Li Ping Tang
Lisa H Smoot
Marina M Mazur
Mark T Dransfield
Roopan F Farris
S Vamsee Raju
P2860
P304
P356
10.1165/RCMB.2013-0228OC
P577
2014-03-01T00:00:00Z